Imaging in diabetic cardiomyopathy

References

• Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34
   PubMed Web of Science ®Google Scholar
• Nichols GA, Gullion CM, Koro CE, et al. The incidence of congestive heart failure in type 2 diabetes: an update. 2004;27:1879-84
   Google Scholar
• Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000;35:1628-37
   PubMed Web of Science ®Google Scholar
• Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001;103:2668-73
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (United Kingdom Prospective Diabetes Study 35): prospective observational study. BMJ 2000;321:405-12
   PubMed Web of Science ®Google Scholar
• Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15
   PubMed Web of Science ®Google Scholar
• Bugger H, Abel ED. Rodent models of diabetic cardiomyopathy. Dis Model Mech 2009;2(9-10):454-66
   PubMedGoogle Scholar
• Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res 2000;87:1123-32
   PubMed Web of Science ®Google Scholar
• Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9
   PubMed Web of Science ®Google Scholar
• Xie Y-W, Wolin MS. Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in Response to Hypoxia/Reoxygenation. Circulation 1996;94:2580-6
   PubMed Web of Science ®Google Scholar
• Mori J, Patel VB, Abo Alrob O, et al. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation. Circ Heart Fail 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Loganathan R, Bilgen M, Al-Hafez B, Smirnova IV. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. J Am Coll Cardiol 2006;48(8):1548-51
   PubMedGoogle Scholar
• Diamant M, Lamb HJ, Groeneveld Y, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. JACC 2003;42(2):328-35
   Google Scholar
• Winhofer Y, Krssák M, Jankovic D, et al. Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects. Diabetes 2012;61:1210-16
   PubMedGoogle Scholar
• Giannetta E, Isidori AM, Galea N, et al. Circulation 2012 Chronic inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging. Circulation 2012;125:2323-33
   PubMed Web of Science ®Google Scholar
• Di Bonito P, Cuomo S, Moio N, et al. Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet Med 1996;13:321-4
   PubMedGoogle Scholar
• Nicolino A, Longobardi G, Furgi G, et al. Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens 1995;8:382-9
   PubMed Web of Science ®Google Scholar
• ZhouY T, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000;97:1784-9
   PubMedGoogle Scholar
• Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 2000;10:238-45
   PubMed Web of Science ®Google Scholar
• Finck BN, Han X, Courtois M, et al. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 2003;100:1226-31
   PubMed Web of Science ®Google Scholar
• Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205
   PubMed Web of Science ®Google Scholar
• Golfman L, Dixon IM, Takeda N, et al. Cardiac sarcolemmal Na+/Ca2+ exchange and Na+-K+ ATPase activities and gene expression in alloxan-induced diabetic rats. Mol Cell Biochem 1998;188:91-101
   PubMedGoogle Scholar
• Hattori Y, Matsuda N, Kimura J, et al. Diminished function and expression of the cardiac Na+-Ca2+ exchanger in diabetic rats: implication in Ca2+ overload. J Physiol 2000;527:85-94
   PubMed Web of Science ®Google Scholar
• Morgan JP, Erny RE, Allen PD, et al. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990;81:21-32
   Google Scholar
• Lebeche D, Davidoff AJ, Hajjar RJ. Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nat Clin Pract Cardiovasc Med 2008;5:715-24
   PubMedGoogle Scholar
• Searls YM, Loganathan R, Smirnova IV, et al. Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia. Cardiovasc Diabetol 2010;8
   PubMedGoogle Scholar
• Trost SU, Belke DD, Bluhm WF, et al. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 2002;51:1166-71
   PubMed Web of Science ®Google Scholar
• Shishehbor MH, Hoogwerf BJ, Schoenhagen P, et al. Relation of hemoglobin A1C to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol 2003;91:1514-17
   PubMedGoogle Scholar
• Zhang L, Cannell MB, Phillips ARJ, et al. Altered calcium homeostasis does not explain the contractile deficit of diabetic cardiomyopathy. Diabetes 2008;57(8):2158-66
   PubMedGoogle Scholar
• Factor S, Okun E, Minase T, et al. Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy? NEJM 1980;302:384-8
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Techigawara M, Ishihata T, et al. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 1997;12:267-74
   PubMed Web of Science ®Google Scholar
• Regan TJ, Lyons MM, Ahmed SS, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977;60:885-99
   Web of Science ®Google Scholar
• Shimizu M, Umeda K, Sugihara N, et al. Collagen remodeling in myocardia of patients with diabetes. J Clin Pathol 1993;46:32-6
   PubMed Web of Science ®Google Scholar
• van Heerebeek L, Hamdani N, Handoko ML, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008;117:43-51
   PubMed Web of Science ®Google Scholar
• Cheung N, Wang JJ, Rogers SL, et al. ARIC (Atherosclerosis Risk In Communities) Study Investigators. Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol 2008;51:1573-8
   PubMed Web of Science ®Google Scholar
• Miettinen H, Haffner SM, Lehto S, et al. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 1996;19:1445-8
   PubMedGoogle Scholar
• Fuller JH, Stevens LK, Wang SL. WHO Multinational Study Group. Risk Factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia 2001;44(Suppl 2):S54-64
   PubMedGoogle Scholar
• Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18(2):258-68
   PubMed Web of Science ®Google Scholar
• Liu Y, Cox S, Morita T, et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ Res 1995;77:638-43
   PubMed Web of Science ®Google Scholar
• Chou E, Suzuma I, Way KJ, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002;373-9
   PubMedGoogle Scholar
• Shapiro BP, Owan TE, Mohammed SF, et al. Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines. Circulation. 2008;118(10):1002-10
   Google Scholar
• Zieman SJ, Melenovsky V, Clattenburg L, et al. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens 2007;25:577-83
   PubMed Web of Science ®Google Scholar
• Bakris GL, Bank AJ, Kass DA, et al. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 2004;17(12 Pt 2):23S-30S
   Google Scholar
• Kahn JK, Zola B, Juni JE, Vinik AI. Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol 1986;7:1303-9
   PubMedGoogle Scholar
• Dinh W, Füth R, Lankisch M, et al. Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiography. Diabet Med 2011;28:311-18
   PubMedGoogle Scholar
• Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991;68:85-9
   PubMed Web of Science ®Google Scholar
• Eguchi K, Boden-Abala B, Jin Z, et al. Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol 2008;101:1787-91
   PubMed Web of Science ®Google Scholar
• Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 2000;101:2271-6
   PubMed Web of Science ®Google Scholar
• Ozasa N, Furukawa Y, Morimoto T, et al. Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes. Hypertens Res 2008;31:425-32
   PubMedGoogle Scholar
• Galdisieri M. Diastolic dysfunction and diabetic cardiomyopathy. Evaluation by Doppler echocardiography. J Am Coll Cardiol 2006;48:1548-51
   PubMedGoogle Scholar
• Ha JW, Lee HC, Kang ES, et al. Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart 2007;93:1571-6
   PubMed Web of Science ®Google Scholar
• Nakai H, Takeuchi M, Nishikage T, et al. Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration. Eur J Echocardiogr 2009;10:926-32
   PubMed Web of Science ®Google Scholar
• Cognet T, Vervueren PL, Dercle L, et al. New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value. Cardiovasc Diabetol 2013;12:84
   PubMedGoogle Scholar
• Shapiro LM. Echocardiographic features of impaired ventricular function in diabetes mellitus. Br Heart J 1982;47:439-44
   PubMedGoogle Scholar
• Mildenberger RR, Bar-Shlomo B, Druck MN. Clinically unrecognized ventricular dysfunction in young diabetic patients. J Am Coll Cardiol 1984;4:234-8
   PubMed Web of Science ®Google Scholar
• Liu JE, Palmieri V, Roman MJ, et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001;37(7):1943-9
   PubMed Web of Science ®Google Scholar
• Jain A, Avendano G, Dharamsey S, et al. Left ventricular diastolic function in hypertension and role of plasma glucose and insulin. Comparison with diabetic heart. Circulation 1996;93:1396-402
   PubMedGoogle Scholar
• Hoeke U, Thijssen J, van Bommel RJ, et al. Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy. Diabetes Care 2013;36:985-91
   PubMedGoogle Scholar
• Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9
   PubMed Web of Science ®Google Scholar
• Poulsen MK, Dahl J, Henriksen J, et al. Left atrial volume index. J Am Coll Cardiol 2013;62:2416-21
   PubMedGoogle Scholar
• Hoyt RH, Collins SM, Skorton DJ, et al. Assessment of fibrosis in infarcted human hearts by analysis of ultrasonic backscatter. Circulation 1985;71:740-4
   PubMedGoogle Scholar
• Ciulla M, Paliotti R, Hess DB, et al. Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization. J Am Soc Echocardiogr 1997;10:657-64
   PubMed Web of Science ®Google Scholar
• Picano E, Pelosi G, Marzilli M, et al. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation 1990;81:58-64
   PubMedGoogle Scholar
• Kosmala W, Przewlocka-Kosmala M, Wojnalowicz A, et al. Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction. Eur Heart J Cardiovasc Imaging 2012;13(6):459-67
   PubMed Web of Science ®Google Scholar
• Krum H, Elsik M, Schneider HG, et al. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the IPRESERVE collagen substudy. Circ Heart Fail 2011;4:561-8
   PubMedGoogle Scholar
• Bertini M, Delgado V, den Uijl DW, et al. Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter. imaging. Circ Cardiovasc Imaging 2010;3:86-93
   PubMedGoogle Scholar
• Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9
   PubMed Web of Science ®Google Scholar
• Bertoni AG, Goff DC Jr, D’Agostino RB Jr, et al. Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2006;29:588-94
   PubMedGoogle Scholar
• Edvardsen T, Gerber BL, Garot J, et al. Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation 2002;106:50-6
   PubMed Web of Science ®Google Scholar
• Chung J, Abraszewski P, Yu X, et al. Paradoxical in- crease in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. J Am Coll Cardiol 2006;47:384-90
   PubMed Web of Science ®Google Scholar
• Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122:138-44
   PubMed Web of Science ®Google Scholar
• Picano E, Pelosi G, Marzilli M, et al. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation 1990;81:58-64
   PubMedGoogle Scholar
• Messroghli DR, Radjenovic A, Kozerke S, et al. Modified Look-Locker inversion recovery (MOLLI) for high- resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-6
   PubMed Web of Science ®Google Scholar
• Messroghli DR, Greiser A, Frohlich M, et al. Optimization and validation of a fully-integrated pulse sequence for Modified Look-Locker Inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 2007;26:1081-6
   PubMed Web of Science ®Google Scholar
• Piechnik SK, Ferreira VM, Dall’Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69
   PubMed Web of Science ®Google Scholar
• Jellis C, Wright W, et al. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging 2011;4:693-702
   PubMed Web of Science ®Google Scholar
• Rao AD, Shah RV, Garg R, et al. Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus. Am J Cardiol 2013;112(1):73-8
   PubMed Web of Science ®Google Scholar
• Lee JJ, Liu S, Nacif MS, Ugander M. Myocardial T1 and extracellular volume fraction mapping at 3 Tesla. J Cardiovasc Magn Reson 2011;13:75
   PubMedGoogle Scholar
• Messroghli DR, Nordmeyer S, Dietrich T, et al. Assessment of diffuse myocardial fibrosis in rats using small-animal look-locker inversion recovery T1 mapping. Circ Cardiovasc Imaging 2011;4:636-40
   PubMed Web of Science ®Google Scholar
• Schelbert EB, Testa SM, Meier CG, et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 2011;13:16
   PubMed Web of Science ®Google Scholar
• Wong TC, Piehler KM, Meier CG, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012;126:1206-16
   PubMed Web of Science ®Google Scholar
• Wong TC, Piehler KM, Kang IA, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 2013; published online June 11, 2013; doi:10.1093/eurheartj/eht193
   Google Scholar
• Young ME, Guthrie PH, Razeghi P, et al. Impaired long chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 2002;51:2587-95
   PubMed Web of Science ®Google Scholar
• Sharma S, Adrogue JV, Golfman L, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004;18:1692-700
   PubMed Web of Science ®Google Scholar
• Toyo-oka T, Nagayama K, Suzuki J, et al. Noninvasive assessment of cardiomyopathy development with simultaneous measurement of topical 1H- and 31P-magnetic resonance spectroscopy. Circulation. 1992;86:295-301
   Google Scholar
• Gadian DG. Nuclear magnetic resonance and its application to living systems. Oxford, Oxford University Press. Am J Physiol 1982;242
   Google Scholar
• Ingwall JS. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscle. Am J Physiol 1982;242(5):H729-44
   Google Scholar
• Szczepaniak LS, Victor RG, Orci L, et al. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 2007;101(8):759-67
   PubMed Web of Science ®Google Scholar
• McGavock JM, Lingvay I, Zib I. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007;116(10):1170-5
   PubMed Web of Science ®Google Scholar
• Faller K, Lygate CA, Neubauer S, et al. H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism. Heart Fail Rev 2013;18:657-68
   PubMedGoogle Scholar
• Nakae I, Mitsunami K, Yoshino T, et al. Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine. J Cardiac Fail 2010;16:812e822
   Google Scholar
• Sasso FC, Carbonara O, Cozzolino D, et al. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients. J Am Coll Cardiol 2000;36:219e26
   Google Scholar
• Stevens MJ, Dayanikli F, Raffel DM, et al. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 1998;31:1575e84
   Google Scholar
• Scognamiglio R, Avogaro A. Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998;31:404-12
   PubMedGoogle Scholar
• Christensen NJ. Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. Diabetes 1974;23:1-8
   PubMed Web of Science ®Google Scholar
• Fushimi H, Inoue T, Kishimo B, et al. Abnormalities in plasma catecholamine accumulation in streptozotocin diabetic rats. Life Sci 1984;35:1077-81
   PubMedGoogle Scholar
• Randle PJ, Newsholme EA, Garland PB. Regulation of glucose uptake by muscle. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 1964;93:652-65
   PubMed Web of Science ®Google Scholar
• Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol 2000;279:E1104-13
   PubMed Web of Science ®Google Scholar
• Herrero P, Peterson L. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2006;47:598-604
   PubMed Web of Science ®Google Scholar
• Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7
   PubMed Web of Science ®Google Scholar
• Kiencke S, Handschin R, von Dahlen R, et al. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail 2010;12:951-7
   PubMed Web of Science ®Google Scholar
• Chung J, Abraszewski P, Yu X, et al. Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. J Am Coll Cardiol 2006;47(2):384-90
   PubMed Web of Science ®Google Scholar